Drug-resistance mechanisms and tuberculosis drugs

Lancet. 2015 Jan 24;385(9965):305-7. doi: 10.1016/S0140-6736(14)62450-8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Diarylquinolines / therapeutic use*
  • Drug Approval
  • Humans
  • Mutation / genetics
  • Nitroimidazoles / therapeutic use*
  • Oxazoles / therapeutic use*
  • Tuberculosis, Multidrug-Resistant / genetics
  • Tuberculosis, Multidrug-Resistant / prevention & control*

Substances

  • Antitubercular Agents
  • Diarylquinolines
  • Nitroimidazoles
  • OPC-67683
  • Oxazoles
  • bedaquiline